Breast Cancer Drug Fulvestrant Sees Over 80% Price Drop in China's National Volume-Based Procurement

Gelonghui November 6th | According to the Science and Technology Innovation Board Daily, at the bidding site of the ninth batch of national drug bulk procurement, it was learned that after the centralized procurement bidding, the price of fulvestrant (specification: 5ml:0.25g), a long-acting preparation for breast cancer, dropped from thousands of yuan to hundreds of yuan. CHIATAI TIANQING quoted 148.3 yuan per vial, Hansoh Pharma 150 yuan per vial, and Qilu Pharmaceutical, Hangzhou Jiuyuan Gene Engineering Co.,Ltd., and Sichuan Huiyu Pharmaceutical Co., Ltd. all quoted around 250-300 yuan per vial.